Knobbe Martens Olson & Bear LLP
Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof
Disclosed are a crystalline or amorphous form of steroid derivative FXR agonist (formula I), and a preparation method therefor, and a crystalline composition and pharmaceutical composition comprising the crystalline or amorphous form, and the use of same in the preparation of a drug for treating or preventing various conditions associated with FXR.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A A A C A A A C A
A61P A61P A61P C07B A61K A61P A61P C07J A61P
inventional inventional inventional additional inventional inventional inventional inventional inventional
Xiaolin Peng Weidong Hualing Haiying
Li Li Li Xiao He